Skip to main content
. 2018 Oct 4;8(9):e022348. doi: 10.1136/bmjopen-2018-022348

Figure 2.

Figure 2

Forest plots depicting the effect of PCSK9-mAbs on hs-CRP. PCSK9-mAb, proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibody; hs-CRP, high-sensitivity C-reactive protein.